Human CD172a-SIRPA recombinant protein

Reference: PX-P6120-100
Product nameHuman CD172a-SIRPA recombinant protein
Uniprot IDP78324
Origin speciesHomo sapiens (Human)
Expression systemEukaryotic expression
Molecular weight41.14 kDa
Protein delivered with Tag?C-Terminal His Tag
Purity estimated>85% by SDS-PAGE
Buffer0.01M PBS, pH 7.4.
Delivery conditionDry Ice
Storage condition4°C for short term (1 week), -20°C or -80°C for long term (avoid freezing/thawing cycles; addition of 20-40% glycerol improves cryoprotection)
BrandProteoGenix
Host speciesMammalian cells
ApplicationsELISA,WB
Fragment TypeMet1-Arg370
Aliases /SynonymsBIT, Signal-regulatory protein alpha-1, Brain Ig-like molecule with tyrosine-based activation motifs, MFR, SIRP, Sirp-alpha-1, Sirp-alpha-2, PTPNS1, SIRPA, SHP substrate 1, CD172 antigen-like family member A, Sirp-alpha-3, Inhibitory receptor SHPS-1, Signal-regulatory protein alpha-3, CD172a, Tyrosine-protein phosphatase non-receptor type substrate 1, MyD-1 antigen, Bit, SHPS-1, Macrophage fusion receptor, Signal-regulatory protein alpha-2, SHPS1, MYD1, p84
ReferencePX-P6120
NoteFor research use only

Description of Human CD172a-SIRPA recombinant protein

General information on Human CD172a-SIRPA recombinant protein

Structure

Human CD172a-SIRPA recombinant protein is a type I transmembrane glycoprotein composed of two extracellular Ig-like domains, a transmembrane domain, and a short cytoplasmic tail. It is encoded by the SHPS-1 gene.

Activity

CD172a-SIRPA protein is a member of the immunoglobulin superfamily that is involved in the regulation of cell-cell interactions. It is known to bind to the CD47 receptor on other cells and inhibit their activation, making it an important immune checkpoint protein.

Application

CD172a-SIRPA recombinant protein has potential applications in the development of antibody-drug conjugates (ADCs) for cancer therapy. It can be used to target cancer cells by binding to CD47 receptors on their surface. This binding triggers an immune response that leads to the destruction of the cancer cells.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Human CD172a-SIRPA recombinant protein”

Your email address will not be published. Required fields are marked *

Related products

Blinatumomab Biosimilar – Anti-CD19, CD3E mAb – Research Grade
Biosimilar

Blinatumomab Biosimilar – Anti-CD19, CD3E mAb – Research Grade

PX-TA1067 400€

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.






    Cart (0 Items)

    Your cart is currently empty.

    View Products